Notice: Undefined index: HTTP USER AGENT in
/home/legalease/legalbusiness/releases/20210224120424/wp-content/plugins/social-warfare-pro/lib/social-networks/SWP Whatsapp.php on line
49
/home/legalease/legalbusiness/releases/20210224120424/wp-content/plugins/social-warfare-pro/lib/social-networks/SWP Whatsapp.php on line
49
/home/legalease/legalbusiness/releases/20210224120424/wp-content/plugins/social-warfare-pro/lib/social-networks/SWP Whatsapp.php on line
49
/home/legalease/legalbusiness/releases/20210224120424/wp-content/plugins/social-warfare-pro/lib/social-networks/SWP Whatsapp.php on line
49
/home/legalease/legalbusiness/releases/20210224120424/wp-content/plugins/social-warfare-pro/lib/social-networks/SWP Whatsapp.php on line
49
05 FEBRUARY 2021 Immunocore Holdings plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, today announced the pricing of its upsized initial public offering in the United States of 9,935,896 American Depositary Shares ( ADSs ) representing 9,935,896 ordinary shares at an initial public offering price of $26.00 per ADS, for total gross proceeds of approximately $258.3 million. All ADSs sold in the offering were offered by Immunocore. The ADSs are expected to begin trading on The Nasdaq Global Select Market on February 5, 2021 under the ticker symbol IMCR. In addition, Immunocore has granted the underwriters a 30-day option to purchase up to an additional 1,490,384 ADSs at the initial public offering price, less underwriting discounts and commissions. The offering
Landos Prices $ 100 Million IPO RTW Venture Fund Limited (the Company ), the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to note the announcement by its portfolio company Landos Biopharma, Inc. ( Landos ) on 03 February 2021 of its pricing of a $ 100 million initial public offering ( IPO ) and admission to trade on Nasdaq Global Market under ticker LABP . Landos is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oral therapeutics for patients with autoimmune diseases. The lead asset BT-11 is a novel, oral, gut-restricted therapeutic candidate for the treatment of ulcerative colitis and Crohn s disease that targets the LANCL2 pathway.
Mum slams free school meal food parcel as Marcus Rashford says it s not good enough Mirror 12/01/2021
Replay Video UP NEXT
A furious mum has slammed the free school meals scheme after she says she was sent just a few pounds worth of food to feed her children for 10 days.
Parents of children who would normally qualify for free school meals have been given the option of food parcels or vouchers as schools close for remote learning.
Going by the Twitter handle @RoadsideMum, the unnamed woman shared a photo of a delivery which she estimated cost £5.22, rather than the £30 vouchers she is entitled to.
Mum slams free school meals parcel as Marcus Rashford agrees it s unacceptable dailystar.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailystar.co.uk Daily Mail and Mail on Sunday newspapers.